Jun 17, 2020
Akero Therapeutics Doses First Patient in Expansion of Phase 2a Trial in NASH
May 11, 2020
DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs
Mar 05, 2020
Zydus Announces World's First Drug for the Treatment of Non-Cirrhotic NASH
Jan 29, 2020
Called a 1st in U.S.: Living liver donors generously swap, saving 2 recipients
Jan 15, 2020
2019 Most Successful Year Ever Recorded for Organ and Tissue Donation in Colorado and Wyoming
Jan 06, 2020
Tampa General Hospital is First in Florida to Use New Organ Transplant System for Three Different Organs
Dec 16, 2019
Akero Therapeutics Completes Enrollment in Phase 2a Study in NASH
Nov 13, 2019
J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease
Nov 06, 2019
DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results
Oct 22, 2019
HighTide Therapeutics Announces Completion of Enrollment in Phase 2a NASH Study of HTD1801
Oct 16, 2019
Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH
Sep 12, 2019
Tower Health Recruits Nationally Recognized Kidney and Liver Transplant Team; Opens Tower Health Transplant Institute
Aug 08, 2019
Laboratory for Advanced Medicine Strengthens Hepatology Board with Addition of Three Distinguished Medical Doctors
Jul 31, 2019
Olympus ORBEYE Video Microscope and THUNDERBEAT Energy Device Enable Lifesaving Transplant
Jun 03, 2019
State approves Northwell Health liver transplant program
Jun 03, 2019
Hemoglobin Oxygen Therapeutics LLC Announces Multiple Presentations Using Hemopure® in Donor Livers Previously Rejected for Transplant.
Apr 11, 2019
89bio Announces Preclinical Data That Demonstrate Potential Utility of BIO89-100 for Treatment of NASH
Mar 18, 2019
Astellas Launches PROGRAF® Granules (tacrolimus for oral suspension) in the U.S. for Pediatric Liver, Heart, and Kidney Transplant Patients
Feb 18, 2019
The global liver cancer diagnostics market size is expected to reach USD 15.4 billion by 2025
Feb 13, 2019
Hemoglobin Oxygen Therapeutics LLC Announce Updated Results From The Netherlands Leading Liver Transplant Hospital